Although physical differences exist between male and female hearts as women's hearts are smaller and have thinner walls, nevertheless, the diagnostic criteria for some heart diseases are the same for both.
"This means that women's hearts must grow disproportionately more than men's before meeting the same risk criteria," the researchers argued in the paper published in the journal Frontiers in Physiology.
She said this gender-neutral approach found women are particularly at a higher risk of "first-degree atrioventricular (AV) block, a disorder affecting the heartbeat, and dilated cardiomyopathy, a disease of the heart muscle, than men." Double and 1.4 times more respectively.
Skyler St. Pierre, a researcher at Stanford University's Living Matter Lab, US, said, "We found that gender-neutral criteria fail to adequately diagnose women. If gender-specific criteria are used, it The lower the diagnosis the less serious it will be.,
He added, "We have found the electrocardiogram (EKG) to be the best test for improving heart disease detection for both men and women."
To create a more accurate cardiovascular risk model based on gender-specific criteria, the team added four metrics not considered in the popular Framingham Risk Score: cardiac magnetic resonance imaging, pulse wave analysis, EKG and carotid ultrasound.
The Framingham Risk Score is a popular system for diagnosing cardiovascular risks based on age, gender, cholesterol level, and blood pressure. The diagnostic system can predict how likely a person is to develop heart disease within the next 1 year.
The team used data from more than 20,000 individuals in the UK Biobank who have undergone these trials.Using machine learning, researchers determined which metrics tested were most effective in improving heart disease detection in both EKG men and women. However, this does not mean that traditional risk factors are not important tools for risk assessment, the researchers said.
He added, “We propose that physicians first screen people using a simple survey taking into account traditional risk factors, and then perform a second step of screening using EKG for high-risk patients."
"This means that women's hearts must grow disproportionately more than men's before meeting the same risk criteria," the researchers argued in the paper published in the journal Frontiers in Physiology.
She said this gender-neutral approach found women are particularly at a higher risk of "first-degree atrioventricular (AV) block, a disorder affecting the heartbeat, and dilated cardiomyopathy, a disease of the heart muscle, than men." Double and 1.4 times more respectively.
Skyler St. Pierre, a researcher at Stanford University's Living Matter Lab, US, said, "We found that gender-neutral criteria fail to adequately diagnose women. If gender-specific criteria are used, it The lower the diagnosis the less serious it will be.,
He added, "We have found the electrocardiogram (EKG) to be the best test for improving heart disease detection for both men and women."
To create a more accurate cardiovascular risk model based on gender-specific criteria, the team added four metrics not considered in the popular Framingham Risk Score: cardiac magnetic resonance imaging, pulse wave analysis, EKG and carotid ultrasound.
The Framingham Risk Score is a popular system for diagnosing cardiovascular risks based on age, gender, cholesterol level, and blood pressure. The diagnostic system can predict how likely a person is to develop heart disease within the next 1 year.
The team used data from more than 20,000 individuals in the UK Biobank who have undergone these trials.Using machine learning, researchers determined which metrics tested were most effective in improving heart disease detection in both EKG men and women. However, this does not mean that traditional risk factors are not important tools for risk assessment, the researchers said.
He added, “We propose that physicians first screen people using a simple survey taking into account traditional risk factors, and then perform a second step of screening using EKG for high-risk patients."